Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3323 ARTÍCULOS , VIENDO DEL 1246 AL 1260

Redox control of brain calcium in health and disease

Hidalgo C, Carrasco MA.

Antioxid Redox Signal. 2011 Apr 1;14(7):1203-7. doi: 10.1089/ars.2010.3711. Epub 2011 Feb 9.

Sleep disorders in neurodegenerative diseases other than Parkinson's disease

Auger RR, Boeve BF.

Handb Clin Neurol. 2011;99:1011-50. doi: 10.1016/B978-0-444-52007-4.00020-5.

Insight into the mode of action of the LRRK2 Y1699C pathogenic mutant

Daniëls V, Vancraenenbroeck R, Law BM, Greggio E, Lobbestael E, Gao F, De Maeyer M, Cookson MR, Harvey K, Baekelandt V, Taymans JM.

J Neurochem. 2011 Jan;116(2):304-15. doi: 10.1111/j.1471-4159.2010.07105.x.

Chronic traumatic encephalopathy: a potential late effect of sport-related concussive and subconcussive head trauma

Gavett BE, Stern RA, McKee AC.

Clin Sports Med. 2011 Jan;30(1):179-88, xi. doi: 10.1016/j.csm.2010.09.007.

Exercise alleviates Parkinsonism: clinical and laboratory evidence

Archer T, Fredriksson A, Johansson B.

Acta Neurol Scand. 2011 Feb;123(2):73-84. doi: 10.1111/j.1600-0404.2010.01360.x.

Ageing and protein aggregation-mediated disorders: from invertebrates to mammals

Dillin A, Cohen E.

Philos Trans R Soc Lond B Biol Sci. 2011 Jan 12;366(1561):94-8. doi: 10.1098/rstb.2010.0271.

To eat or not to eat: neuronal metabolism, mitophagy, and Parkinson's disease

Gusdon AM, Chu CT.

Antioxid Redox Signal. 2011 May 15;14(10):1979-87. doi: 10.1089/ars.2010.3763. Epub 2011 Mar 3.

The relevance of iron in the pathogenesis of Parkinson's disease

Sian-Hülsmann J, Mandel S, Youdim MB, Riederer P.

J Neurochem. 2011 Sep;118(6):939-57. doi: 10.1111/j.1471-4159.2010.07132.x. Epub 2011 Jan 31.

Dopamine agonists in the treatment of prolactinoma: are they still first choice?

Ogilvie CM, Milsom SR.

Intern Med J. 2011 Feb;41(2):156-61. doi: 10.1111/j.1445-5994.2010.02410.x.

Ion channels on microglia: therapeutic targets for neuroprotection

Skaper SD.

CNS Neurol Disord Drug Targets. 2011 Feb;10(1):44-56. doi: 10.2174/187152711794488638.

Endogenous neuroprotection in chronic neurodegenerative disorders: with particular regard to the kynurenines

Zádori D, Klivényi P, Plangár I, Toldi J, Vécsei L.

J Cell Mol Med. 2011 Apr;15(4):701-17. doi: 10.1111/j.1582-4934.2010.01237.x.

Neuronal hemoglobin is reduced in Alzheimer's disease, argyrophilic grain disease, Parkinson's disease, and dementia with Lewy bodies

Ferrer I, Gómez A, Carmona M, Huesa G, Porta S, Riera-Codina M, Biagioli M, Gustincich S, Aso E.

J Alzheimers Dis. 2011;23(3):537-50. doi: 10.3233/JAD-2010-101485.

Electroconvulsive therapy in children and adolescents

Shoirah H, Hamoda HM.

Expert Rev Neurother. 2011 Jan;11(1):127-37. doi: 10.1586/ern.10.178.

What neurophysiological recordings tell us about cognitive and behavioral functions of the human subthalamic nucleus

Marceglia S, Fumagalli M, Priori A.

Expert Rev Neurother. 2011 Jan;11(1):139-49. doi: 10.1586/ern.10.184.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias